FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2773465543> ?p ?o ?g. }

• W2773465543 endingPage "50" @default.
• W2773465543 startingPage "37" @default.
• W2773465543 abstract "Bile acids have been implicated as important regulators of glucose metabolism via activation of FXR and GPBAR1. We have previously shown that FGF19 can modulate glucose handling by suppressing the activity of hypothalamic AGRP/NPY neurons. As bile acids stimulate the release of FGF19/FGF15 into the circulation, we pursued the potential of bile acids to improve glucose tolerance via a gut-brain axis involving FXR and FGF15/FGF19 within enterocytes and FGF receptors on hypothalamic AGRP/NPY neurons.A 5-day gavage of taurocholic acid, mirroring our previous protocol of a 5-day FGF19 treatment, was performed. Oral glucose tolerance tests in mice with genetic manipulations of FGF signaling and melanocortin signaling were used to define a gut-brain axis responsive to bile acids.The taurocholic acid gavage led to increased serum concentrations of taurocholic acid as well as increases of FGF15 mRNA in the ileum and improved oral glucose tolerance in obese (ob/ob) mice. In contrast, lithocholic acid, an FXR antagonist but a potent agonist for GPBAR1, did not improve glucose tolerance. The positive response to taurocholic acid is dependent upon an intact melanocortinergic system as obese MC4R-null mice or ob/ob mice without AGRP did not show improvements in glucose tolerance after taurocholate gavage. We also tested the FGF receptor isoform necessary for the bile acid response, using AGRP:Fgfr1-/- and AGRP:Fgfr2-/- mice. While the absence of FGFR1 in AGRP/NPY neurons did not alter glucose tolerance after taurocholate gavage, manipulations of Fgfr2 caused bidirectional changes depending upon the experimental model. We hypothesized the existence of an endogenous hypothalamic FGF, most likely FGF17, that acted as a chronic activator of AGRP/NPY neurons. We developed two short peptides based on FGF8 and FGF17 that should antagonize FGF17 action. Both of these peptides improved glucose homeostasis after a 4-day course of central and peripheral injections. Significantly, daily average blood glucose from continuous glucose monitoring was reduced in all tested animals but glucose concentrations remained in the euglycemia range.We have defined a gut-brain axis that regulates glucose metabolism mediated by antagonistic fibroblast growth factors. From the intestine, bile acids stimulate FGF15 secretion, leading to activation of the FGF receptors in hypothalamic AGRP/NPY neurons. FGF receptor intracellular signaling subsequently silences AGRP/NPY neurons, leading to improvements of glucose tolerance that are likely mediated by the autonomic nervous system. Finally, short peptides that antagonize homodimeric FGF receptor signaling within the hypothalamus have beneficial effects on glucose homeostasis without inducing hypoglycemia. These peptides could provide a new mode of regulating glucose metabolism." @default.
• W2773465543 created "2017-12-22" @default.
• W2773465543 creator A5007853808 @default.
• W2773465543 creator A5015804995 @default.
• W2773465543 creator A5017567018 @default.
• W2773465543 creator A5041203436 @default.
• W2773465543 creator A5047945440 @default.
• W2773465543 creator A5066893639 @default.
• W2773465543 creator A5080117526 @default.
• W2773465543 date "2018-02-01" @default.
• W2773465543 modified "2023-10-16" @default.
• W2773465543 title "A gut–brain axis regulating glucose metabolism mediated by bile acids and competitive fibroblast growth factor actions at the hypothalamus" @default.
• W2773465543 cites W1501383339 @default.
• W2773465543 cites W1555526329 @default.
• W2773465543 cites W1963587340 @default.
• W2773465543 cites W1979433345 @default.
• W2773465543 cites W1992149698 @default.
• W2773465543 cites W1993313718 @default.
• W2773465543 cites W1994744366 @default.
• W2773465543 cites W1998864434 @default.
• W2773465543 cites W2014389623 @default.
• W2773465543 cites W2019441910 @default.
• W2773465543 cites W2025619064 @default.
• W2773465543 cites W2026300445 @default.
• W2773465543 cites W2026663929 @default.
• W2773465543 cites W2035391709 @default.
• W2773465543 cites W2038122889 @default.
• W2773465543 cites W2046811888 @default.
• W2773465543 cites W2048206988 @default.
• W2773465543 cites W2048285167 @default.
• W2773465543 cites W2048438803 @default.
• W2773465543 cites W2053581007 @default.
• W2773465543 cites W2059413013 @default.
• W2773465543 cites W2063966134 @default.
• W2773465543 cites W2067168283 @default.
• W2773465543 cites W2069143595 @default.
• W2773465543 cites W2071315178 @default.
• W2773465543 cites W2083422904 @default.
• W2773465543 cites W2095509444 @default.
• W2773465543 cites W2096418655 @default.
• W2773465543 cites W2102311237 @default.
• W2773465543 cites W2102434679 @default.
• W2773465543 cites W2102818798 @default.
• W2773465543 cites W2105096193 @default.
• W2773465543 cites W2134897177 @default.
• W2773465543 cites W2161418574 @default.
• W2773465543 cites W2163548934 @default.
• W2773465543 cites W2166264058 @default.
• W2773465543 cites W2167430231 @default.
• W2773465543 cites W2171398834 @default.
• W2773465543 cites W2186849372 @default.
• W2773465543 doi "https://doi.org/10.1016/j.molmet.2017.12.003" @default.
• W2773465543 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5985052" @default.
• W2773465543 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29290621" @default.
• W2773465543 hasPublicationYear "2018" @default.
• W2773465543 type Work @default.
• W2773465543 sameAs 2773465543 @default.
• W2773465543 citedByCount "56" @default.
• W2773465543 countsByYear W27734655432018 @default.
• W2773465543 countsByYear W27734655432019 @default.
• W2773465543 countsByYear W27734655432020 @default.
• W2773465543 countsByYear W27734655432021 @default.
• W2773465543 countsByYear W27734655432022 @default.
• W2773465543 countsByYear W27734655432023 @default.
• W2773465543 crossrefType "journal-article" @default.
• W2773465543 hasAuthorship W2773465543A5007853808 @default.
• W2773465543 hasAuthorship W2773465543A5015804995 @default.
• W2773465543 hasAuthorship W2773465543A5017567018 @default.
• W2773465543 hasAuthorship W2773465543A5041203436 @default.
• W2773465543 hasAuthorship W2773465543A5047945440 @default.
• W2773465543 hasAuthorship W2773465543A5066893639 @default.
• W2773465543 hasAuthorship W2773465543A5080117526 @default.
• W2773465543 hasBestOaLocation W27734655431 @default.
• W2773465543 hasConcept C104317684 @default.
• W2773465543 hasConcept C106646824 @default.
• W2773465543 hasConcept C126322002 @default.
• W2773465543 hasConcept C134018914 @default.
• W2773465543 hasConcept C170493617 @default.
• W2773465543 hasConcept C185592680 @default.
• W2773465543 hasConcept C203862802 @default.
• W2773465543 hasConcept C2775936931 @default.
• W2773465543 hasConcept C2777391703 @default.
• W2773465543 hasConcept C2778620825 @default.
• W2773465543 hasConcept C2779306644 @default.
• W2773465543 hasConcept C2779399885 @default.
• W2773465543 hasConcept C2780480987 @default.
• W2773465543 hasConcept C3018667095 @default.
• W2773465543 hasConcept C39321552 @default.
• W2773465543 hasConcept C55493867 @default.
• W2773465543 hasConcept C63932345 @default.
• W2773465543 hasConcept C71924100 @default.
• W2773465543 hasConcept C74373430 @default.
• W2773465543 hasConcept C86339819 @default.
• W2773465543 hasConcept C86803240 @default.
• W2773465543 hasConcept C89673097 @default.
• W2773465543 hasConceptScore W2773465543C104317684 @default.
• W2773465543 hasConceptScore W2773465543C106646824 @default.
• W2773465543 hasConceptScore W2773465543C126322002 @default.

• next